A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine if Dimebon is safe and effective in patients with moderate to severe Alzheimer's disease.

Phase 3

Medivation, Inc.

Pfizer